189 Avsnitt

  1. Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions

    Publicerades: 2022-01-31

  2. Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease

    Publicerades: 2022-01-26

  3. Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

    Publicerades: 2022-01-14

  4. Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

    Publicerades: 2022-01-10

  5. Strategies for Secondary AML and Emerging Therapies for AML

    Publicerades: 2022-01-10

  6. Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

    Publicerades: 2022-01-10

  7. An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    Publicerades: 2022-01-10

  8. Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    Publicerades: 2021-12-22

  9. Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    Publicerades: 2021-12-22

  10. Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer

    Publicerades: 2021-12-17

  11. The Evolving Role of TKIs in First-line Treatment of Advanced HCC

    Publicerades: 2021-12-14

  12. Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

    Publicerades: 2021-11-23

  13. Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer

    Publicerades: 2021-11-23

  14. Overcoming Acquired Resistance With Second-Generation TRK Inhibitors

    Publicerades: 2021-11-09

  15. Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

    Publicerades: 2021-11-02

  16. PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

    Publicerades: 2021-10-26

  17. Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Publicerades: 2021-10-21

  18. First-Generation TRK Inhibitors: Clinical Evidence and Indications

    Publicerades: 2021-10-15

  19. PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

    Publicerades: 2021-10-14

  20. Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

    Publicerades: 2021-10-08

5 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site